Ozagrel sodium glucose injection

[Specification] 100ml

[Indications] Ozagrel Sodium Injection is used for the improvement of motor impairment associated with acute cerebral thrombosis. In Japan, approved indications also include the improvement of cerebral vasospasm and associated cerebral ischemic symptoms following surgery for subarachnoid hemorrhage. The approved indications depend on the applicable national product authorization.

[Usage and dosage] Ozagrel sodium is administered by continuous intravenous infusion after dilution with an appropriate electrolyte solution or glucose solution. According to the Japanese prescribing information, for motor impairment associated with acute cerebral thrombosis, the usual adult dose is 80 mg per infusion, administered over two hours twice daily for approximately two weeks. For cerebral vasospasm and associated ischemic symptoms following surgery for subarachnoid hemorrhage, the usual adult daily dose is 80 mg by continuous intravenous infusion over 24 hours, preferably continued for two weeks. Dosage should be adjusted according to age and clinical condition and must follow the approved labeling for the specific formulation.